Insider Trading & Ownership - ONETTO NICOLE

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ONETTO NICOLE

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-12
Option Award
2023-06-14
5:20 pm
N/A
2033-06-11
Bolt Biotherapeutics Inc.BOLTONETTO NICOLE
Director
25,000$025,000
(Direct)
View
2022-06-10
Option Award
2022-06-10
6:26 pm
N/A
2032-06-09
Bolt Biotherapeutics Inc.BOLTONETTO NICOLE
Director
25,000$025,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
5:07 pm
N/A
2032-06-09
Viracta Therapeutics Inc.VIRXONETTO NICOLE
Director
40,000$040,000
(Direct)
View
2022-03-24
Option Award
2022-03-28
3:19 pm
N/A
2032-03-23
Bolt Biotherapeutics Inc.BOLTONETTO NICOLE
Director
34,367$034,367
(Direct)
View
2021-12-14
Option Award
2021-12-16
4:20 pm
N/A
2031-12-13
Bolt Biotherapeutics Inc.BOLTONETTO NICOLE
Director
27,860$027,860
(Direct)
View

Ownership
2021-12-16
4:15 pm
N/A
N/A
Bolt Biotherapeutics Inc.BOLTONETTO NICOLE
Director
0$00
(Direct)
View
2021-03-26
Option Award
2021-03-30
8:25 pm
N/A
2031-03-26
Viracta Therapeutics Inc.VIRXONETTO NICOLE
Director
80,000$080,000
(Direct)
View
2020-06-30
Option Award
2020-07-01
5:05 pm
N/A
2030-06-30
SUNESIS PHARMACEUTICALS INCSNSSONETTO NICOLE
Director
45,000$045,000
(Direct)
View
2019-09-30
Option Award
2019-10-01
2:29 pm
N/A
2029-09-30
SUNESIS PHARMACEUTICALS INCSNSSONETTO NICOLE
Director
90,000$090,000
(Direct)
View
2019-06-11
Option Award
2019-06-12
5:52 pm
N/A
2029-06-11
Sierra Oncology Inc.SRRAONETTO NICOLE
Director
30,000$030,000
(Direct)
View